Visian ICL® in Newport Beach, Orange County
New Procedure Now Available For Those Unsuitable For LASIK
Feinerman Vision Center is among the first in the nation to perform the Phakic IOL (the medical term for Visian ICL®) procedure. Recently approved by the FDA, the procedure involves surgically inserting a special contact lens inside the eye to offer patients, who were not previously suitable for Orange County LASIK, a life without dependence on glasses or contact lenses.
Visian ICL® is best suited for people who have thin corneas or prescriptions that reduce them to wearing "coke bottle glasses," making the LASIK procedure either too dangerous or impractical to perform. One major advantage of the Visian ICL® over the Veriseye™ implantable lens is that it can be injected through a much smaller incision, and therefore does not require sutures. Dr. Feinerman offers the Visian ICL® as an excellent alternative for patients with extreme nearsightedness, extreme farsightedness, and special conditions.
This simple procedure is performed on an outpatient basis. Dr. Feinerman makes a small incision in the cornea and inserts the foldable lens between the iris and the natural crystalline lens. The procedure takes only 15 to 30 minutes for each eye and only requires topical anesthesia (numbing eye drops). Typically, patients can see clearly within a few hours after the procedure.
Because of the positioning of the Visian ICL®, it is invisible to the patient and others. Another added benefit with the Visian ICL® is that it avoids contact with other eye structures, providing safety, stability, comfort, and predictable outcomes. Once in place, the lens stays in place indefinitely and should require no maintenance.
The Visian ICL® lens is made of an advanced material called Collamer® that provides exceptionally clear vision and practically eliminates reflectance of light that can cause glare, halos, and compromised night vision. A highly biocompatible material, Collamer® does not trigger an inflammatory response in the body and minimizes the occurrence of inflammation, induced astigmatism and other complications.
More than 50,000 patients worldwide have undergone the Visian ICL® procedure. The lenses have been subjected to numerous scientific studies and continuing refinement over time. In a rigorous U.S. clinical trial, the satisfaction rate among patients was impressive: 99.4 percent reported satisfaction three years after the procedure.
we believe that getting
involved with our communities
is essential in building good
will & encouraging growth in society. Community Relations